Skip to Main Content
Contribute Try STAT+ Today

Wendell Lim stared at the video playing on his computer screen in amazement. In the inky dark, a yellow blob pulsed: a brain tumor lit up with fluorescent tags. From the edges of the frame, T cells glowing blue crept toward it. When they reached the blob, a switch seemed to flip, and the blue cells turned green.

Lim is a biophysical chemist at the University of California, San Francisco. But what he really does is hack cells. For the last five years, his lab had been working on a new version of CAR-T therapy, re-engineering human immune cells to attack a particularly deadly form of brain cancer. Now those souped up cells had been pumped into a mouse with a human tumor growing in its brain. Lim was watching his armies of fluorescent cellbots lay surgical siege to the Frankencancer on a video feed captured from inside the animal’s skull with a pair of lasers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • My wife just died from a brain infection of Anaplastic Astrocytoma. Do any of the companies in your article have the ability to identify this cancer, prior to a person’s death?

Comments are closed.